Cargando…

Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors

In the present study, novel series of kojic acid derivatives conjugated to amino pyridine moiety were designed and synthesized to explore their inhibitory activity against tyrosinase. To this end, the structure of all derivatives was characterized by (1)H NMR, (13)C NMR, FT-IR, and elemental analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezapour Niri, Davood, Sayahi, Mohammad Hosein, Behrouz, Somayeh, Moazzam, Ali, Rasekh, Fatemeh, Tanideh, Nader, Irajie, Cambyz, Seif Nezhad, Mohammad, Larijani, Bagher, Iraji, Aida, Mahdavi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682633/
https://www.ncbi.nlm.nih.gov/pubmed/38034733
http://dx.doi.org/10.1016/j.heliyon.2023.e22009
_version_ 1785151018462347264
author Rezapour Niri, Davood
Sayahi, Mohammad Hosein
Behrouz, Somayeh
Moazzam, Ali
Rasekh, Fatemeh
Tanideh, Nader
Irajie, Cambyz
Seif Nezhad, Mohammad
Larijani, Bagher
Iraji, Aida
Mahdavi, Mohammad
author_facet Rezapour Niri, Davood
Sayahi, Mohammad Hosein
Behrouz, Somayeh
Moazzam, Ali
Rasekh, Fatemeh
Tanideh, Nader
Irajie, Cambyz
Seif Nezhad, Mohammad
Larijani, Bagher
Iraji, Aida
Mahdavi, Mohammad
author_sort Rezapour Niri, Davood
collection PubMed
description In the present study, novel series of kojic acid derivatives conjugated to amino pyridine moiety were designed and synthesized to explore their inhibitory activity against tyrosinase. To this end, the structure of all derivatives was characterized by (1)H NMR, (13)C NMR, FT-IR, and elemental analysis. Next, all derivatives were evaluated against tyrosinase compared to the kojic acid as positive control and exhibited different inhibitory potencies. Furthermore, the antioxidant potential of all derivatives was determined. The kinetic analysis of the most active agent revealed that 3-hydroxy-6-(hydroxymethyl)-2-((3-nitrophenyl)(pyridin-2-ylamino)methyl)-4H-pyran-4-one (4h) binds to the enzyme in the uncompetitive mode of action. The docking analysis and molecular dynamic simulations showed considerable binding affinity and significant interactions with tyrosinase enzyme to target the melanogenesis pathway, proposing them as potent candidates to control hyperpigmentation in the future.
format Online
Article
Text
id pubmed-10682633
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106826332023-11-30 Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors Rezapour Niri, Davood Sayahi, Mohammad Hosein Behrouz, Somayeh Moazzam, Ali Rasekh, Fatemeh Tanideh, Nader Irajie, Cambyz Seif Nezhad, Mohammad Larijani, Bagher Iraji, Aida Mahdavi, Mohammad Heliyon Research Article In the present study, novel series of kojic acid derivatives conjugated to amino pyridine moiety were designed and synthesized to explore their inhibitory activity against tyrosinase. To this end, the structure of all derivatives was characterized by (1)H NMR, (13)C NMR, FT-IR, and elemental analysis. Next, all derivatives were evaluated against tyrosinase compared to the kojic acid as positive control and exhibited different inhibitory potencies. Furthermore, the antioxidant potential of all derivatives was determined. The kinetic analysis of the most active agent revealed that 3-hydroxy-6-(hydroxymethyl)-2-((3-nitrophenyl)(pyridin-2-ylamino)methyl)-4H-pyran-4-one (4h) binds to the enzyme in the uncompetitive mode of action. The docking analysis and molecular dynamic simulations showed considerable binding affinity and significant interactions with tyrosinase enzyme to target the melanogenesis pathway, proposing them as potent candidates to control hyperpigmentation in the future. Elsevier 2023-11-03 /pmc/articles/PMC10682633/ /pubmed/38034733 http://dx.doi.org/10.1016/j.heliyon.2023.e22009 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Rezapour Niri, Davood
Sayahi, Mohammad Hosein
Behrouz, Somayeh
Moazzam, Ali
Rasekh, Fatemeh
Tanideh, Nader
Irajie, Cambyz
Seif Nezhad, Mohammad
Larijani, Bagher
Iraji, Aida
Mahdavi, Mohammad
Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors
title Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors
title_full Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors
title_fullStr Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors
title_full_unstemmed Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors
title_short Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors
title_sort design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682633/
https://www.ncbi.nlm.nih.gov/pubmed/38034733
http://dx.doi.org/10.1016/j.heliyon.2023.e22009
work_keys_str_mv AT rezapourniridavood designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT sayahimohammadhosein designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT behrouzsomayeh designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT moazzamali designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT rasekhfatemeh designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT tanidehnader designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT irajiecambyz designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT seifnezhadmohammad designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT larijanibagher designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT irajiaida designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors
AT mahdavimohammad designsynthesisinvitroandinsilicoevaluationsofkojicacidderivativeslinkedtoaminopyridinemoietyaspotenttyrosinaseinhibitors